WASHINGTON HEALTH STRATEGIES GROUP

Lobbying Income

$4.2M

Filings

268

Unique Clients

Active Period

2009–2025

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2025	$160,000	8	2
2024	$200,000	8	2
2023	$200,000	10	3
2022	$260,000	8	2
2021	$280,000	8	2
2020	$275,000	12	3
2019	$205,000	12	3
2018	$230,000	16	4
2017	$320,000	16	4
2016	$370,000	18	4
2015	$345,000	14	5
2014	$365,000	20	5
2013	$220,000	19	4
2012	$120,000	19	5
2011	$160,000	25	7
2010	$260,000	26	5
2009	$230,000	29	4

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS	$2,785,000	78	2009–2025
QUINTILES TRANSNATIONAL CORPORATION	$925,000	54	2009–2020
AMERICAN MEDICAL INFORMATICS ASSOCIATION, INC.	$260,000	31	2009–2015
LIGHTHOUSE GUILD (FKA JEWISH GUILD FOR THE BLIND)	$145,000	42	2009–2018
ELECTRONIC HEALTHCARE NETWORK ACCREDITATION COMMISSION (EHNAC)	$80,000	28	2016–2023
CVS	$5,000	3	2014
WASHINGTON HEALTH STRATEGIES GROUP	—	2	2011
INMAR	—	2	2015
DIRECTTRUST	—	13	2023–2025
TRANSPLANT CONNECT	—	5	2010
WOLTERS KLUWER PHARMA SOLUTIONS	—	8	2011–2012
PRESS GANEY ASSOCIATES, INC.	—	2	2011

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	245
SENATE	245
Food & Drug Administration (FDA)	130
Health & Human Services, Dept of (HHS)	98
Centers For Medicare and Medicaid Services (CMS)	26
Natl Institutes of Health (NIH)	24
Agency for Healthcare Research & Quality (AHRQ)	14
Government Accountability Office (GAO)	9
Natl Institute of Standards & Technology (NIST)	7

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	264
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 6114th Congress

21st Century Cures Act

Cited source text and reported amounts

21st Century Cures, Conduct of Clinical Trials, FDA, NIH, R&D Tax Credit, Corporate Tax Reform, Drug Safety, HR 6 21st Century Cures Act

Client expense: — · Firm income: $40,000

Matched citations: HR 6

H.R. 6114th Congress

21st Century Cures Act

Cited source text and reported amounts

Conduct of Clinical Trials, Drug Safety, Corporate Tax Reform, FDA, 21st Century Cures, HR 6 21st Century Cures Act

Client expense: — · Firm income: $40,000

Matched citations: HR 6

WASHINGTON HEALTH STRATEGIES GROUP — Lobbying Disclosure | Poliscope